BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-1 out of 1 found
  Current Search:  mo: 435, furoate: 1     
HTML
66%
Merck (MRK) Presents Data from Mometasone Furoate and Formoterol Fumarate Phase III at AAAAI Annual Meeting
Data from two Phase III studies of Mercks (NYSE: MRK) investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma &...
Street Insider:  Mar 2 2010 4:02PM
Matching: furoate 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.